MedTrace Logo

Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder Patients

NCT00985387 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1215

Last updated 2011-10-12

No results posted yet for this study

Summary

The purpose of the study is to assess patient's persistency in maintaining solifenacin treatment for overactive bladder.

Conditions

Interventions

DRUG

Solifenacin

oral

Sponsors & Collaborators

  • Astellas Pharma Korea, Inc.

    collaborator INDUSTRY

  • Astellas Pharma Inc

    lead INDUSTRY

Principal Investigators

  • Use Central Contact · Astellas Pharma Inc

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00985387 on ClinicalTrials.gov